Amag Pharmaceuticals Incorporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amag Pharmaceuticals Incorporation with three other
companies in this sector in the United States:
Meridian Bioscience, Inc.
sales of $196.08 million
of which 74%
was US Diagnostics),
Myriad Genetics Inc
of which 94%
was Diagnostics), and
of which 55%
was Animal Safety).
Amag Pharmaceuticals Incorporation reported sales of $532.09 million
December of 2016.
increase of 27.2%
versus 2015, when the company's sales were $418.28 million.
This was the third consecutive year of growth at Amag Pharmaceuticals Incorporation.